• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market

cafead

Administrator
Staff member
  • cafead   May 02, 2023 at 11:52: AM
via Waking up in the middle of the night to take a pill is the onerous way patients take the world’s top-selling narcolepsy drug, Jazz Pharmaceuticals’ Xyrem.

But there finally is relief from that challenging regimen as the FDA has blessed a longer-acting, once-at-bedtime treatment. Avadel Pharmaceuticals’ Lumryz is a different formulation of the same drug (sodium oxybate) Jazz has used for its treatment for more than two decades.

article source
 

<